Efficacy and safety of prolonged-release melatonin in insomnia patients with diabetes: a randomized, double-blind, crossover study

BACKGROUND: Diabetes is a major comorbidity in insomnia patients. The efficacy and safety of prolonged-release melatonin 2 mg in the treatment of glucose, lipid metabolism, and sleep was studied in 36 type 2 diabetic patients with insomnia (11 men, 25 women, age 46–77 years). METHODS: In a randomize...

Descripción completa

Detalles Bibliográficos
Autores principales: Garfinkel, Doron, Zorin, Mariana, Wainstein, Julio, Matas, Zipora, Laudon, Moshe, Zisapel, Nava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160855/
https://www.ncbi.nlm.nih.gov/pubmed/21887103
http://dx.doi.org/10.2147/DMSO.S23904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3160855/
https://www.ncbi.nlm.nih.gov/pubmed/21887103
http://dx.doi.org/10.2147/DMSO.S23904

Ejemplares similares